These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 15264876

  • 1. In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties.
    Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Forte LR, Volkert WA.
    Bioconjug Chem; 2004; 15(4):872-80. PubMed ID: 15264876
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers.
    Giblin MF, Gali H, Sieckman GL, Owen NK, Hoffman TJ, Volkert WA, Forte LR.
    Breast Cancer Res Treat; 2006 Jul; 98(1):7-15. PubMed ID: 16724166
    [Abstract] [Full Text] [Related]

  • 3. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
    Roosenburg S, Laverman P, Joosten L, Eek A, Oyen WJ, de Jong M, Rutjes FP, van Delft FL, Boerman OC.
    Bioconjug Chem; 2010 Apr 21; 21(4):663-70. PubMed ID: 20302291
    [Abstract] [Full Text] [Related]

  • 4. Selective targeting of E. coli heat-stable enterotoxin analogs to human colon cancer cells.
    Giblin MF, Sieckman GL, Watkinson LD, Daibes-Figueroa S, Hoffman TJ, Forte LR, Volkert WA.
    Anticancer Res; 2006 Apr 21; 26(5A):3243-51. PubMed ID: 17094436
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemical synthesis of Escherichia coli ST(h) analogues by regioselective disulfide bond formation: biological evaluation of an (111)In-DOTA-Phe(19)-ST(h) analogue for specific targeting of human colon cancers.
    Gali H, Sieckman GL, Hoffman TJ, Owen NK, Mazuru DG, Forte LR, Volkert WA.
    Bioconjug Chem; 2002 Apr 21; 13(2):224-31. PubMed ID: 11906259
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM, Beaumier P, Axworthy D, Atcher R, Fritzberg A.
    Nucl Med Biol; 2005 Oct 21; 32(7):741-7. PubMed ID: 16243650
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
    McQuade P, Knight LC, Welch MJ.
    Bioconjug Chem; 2004 Oct 21; 15(5):988-96. PubMed ID: 15366951
    [Abstract] [Full Text] [Related]

  • 11. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
    Schottelius M, Rau F, Reubi JC, Schwaiger M, Wester HJ.
    Bioconjug Chem; 2005 Oct 21; 16(2):429-37. PubMed ID: 15769098
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
    Giblin MF, Sieckman GL, Shelton TD, Hoffman TJ, Forte LR, Volkert WA.
    Nucl Med Biol; 2006 May 21; 33(4):481-8. PubMed ID: 16720239
    [Abstract] [Full Text] [Related]

  • 13. Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.
    Harris TD, Kalogeropoulos S, Nguyen T, Dwyer G, Edwards DS, Liu S, Bartis J, Ellars C, Onthank D, Yalamanchili P, Heminway S, Robinson S, Lazewatsky J, Barrett J.
    Bioconjug Chem; 2006 May 21; 17(5):1294-313. PubMed ID: 16984141
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of the molecular charge on the biodistribution of bombesin analogues labeled with the [99mTc(CO)3]-core.
    García Garayoa E, Schweinsberg C, Maes V, Brans L, Bläuenstein P, Tourwe DA, Schibli R, Schubiger PA.
    Bioconjug Chem; 2008 Dec 21; 19(12):2409-16. PubMed ID: 18998719
    [Abstract] [Full Text] [Related]

  • 17. [111In-DOTA]LTT-SS28, a first pansomatostatin radioligand for in vivo targeting of somatostatin receptor-positive tumors.
    Maina T, Cescato R, Waser B, Tatsi A, Kaloudi A, Krenning EP, de Jong M, Nock BA, Reubi JC.
    J Med Chem; 2014 Aug 14; 57(15):6564-71. PubMed ID: 25007399
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties.
    Parry JJ, Kelly TS, Andrews R, Rogers BE.
    Bioconjug Chem; 2007 Aug 14; 18(4):1110-7. PubMed ID: 17503761
    [Abstract] [Full Text] [Related]

  • 19. Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium.
    Eberle AN, Froidevaux S.
    J Mol Recognit; 2003 Aug 14; 16(5):248-54. PubMed ID: 14523936
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
    Cyr JE, Pearson DA, Wilson DM, Nelson CA, Guaraldi M, Azure MT, Lister-James J, Dinkelborg LM, Dean RT.
    J Med Chem; 2007 Mar 22; 50(6):1354-64. PubMed ID: 17315859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.